EUVIMEDScopri EUVIMED
Open access · CC BY-NC 4.0

Long‐term outcomes of fertility‐sparing treatment in endometrial carcinoma and endometrial intraepithelial neoplasia: Recurrence risk factors over a 9‐year follow‐up

Ya-Ting Hsu iD, Heng-Cheng Hsu iD, Chia-Yi Lee, Wan-Ting Hung, Chi-Hau Chen iD

Acta Obstetricia et Gynecologica Scandinavica · 2025

DOI: 10.1111/aogs.70028 ↗

At a glance

Journal article in Acta Obstetricia et Gynecologica Scandinavica, 2025. Written by Ya-Ting Hsu and 4 co-authors. Institution: Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei, Taiwan. Major MEDLINE topics: Endometrial Neoplasms, Neoplasm Recurrence, Local, Fertility Preservation, Carcinoma in Situ. Cited 3 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: National Taiwan University Hospital.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Introduction

Fertility‐sparing treatments using oral progestins have demonstrated promising oncologic outcomes for endometrial intraepithelial neoplasia and early‐stage endometrial cancer. However, the high recurrence rate remains a major concern, and the literature on long‐term follow‐up outcomes is limited. This study aimed to identify recurrence risk factors by analyzing clinicopathological and molecular profiles in a cohort with a median follow‐up of 9 years. Material and Methods This retrospective study included patients under 45 years of age who were diagnosed with endometrial intraepithelial neoplasia or endometrial cancer and received fertility‐sparing treatments at our center between 2010 and 2021. Patients who achieved complete responses were categorized according to recurrence status. Demographic, clinical, and molecular data were compared between groups. The primary endpoint was to identify risk factors for recurrence; secondary endpoints assessed obstetric and oncologic outcomes in patients with relapse.

Results

Out of 40 patients, 8 underwent hysterectomy within 1.5 years, while 32 responded to treatment and continued follow‐up. The recurrence and non‐recurrence groups contained 20 and 12 patients, respectively, with a median follow‐up of 107.5 months (range, 35–175 months). Multivariate analysis showed that a family history of cancer (HR = 2.597, p = 0.039) and treatment with megestrol acetate as the initial therapy (HR = 3.130, p = 0.021) were independent risk factors for shorter time to recurrence. Although mismatch repair deficiency was positively correlated with recurrence, the association did not reach statistical significance ( p = 0.057). Four out of 24 patients were upstaged after hysterectomy, and all were in the recurrence group. Nine patients (22.5%) achieved pregnancy, with three successfully conceiving after achieving complete response following retreatment.

Conclusions

In patients with long‐term follow‐up after fertility‐sparing treatment, a family history of cancer and initial treatment with megestrol acetate were significantly associated with recurrence.

Subjects

MeSH terms (MEDLINE)

Endometrial NeoplasmsNeoplasm Recurrence, LocalFertility PreservationCarcinoma in SituHumansFemaleRetrospective StudiesAdultFollow-Up StudiesRisk FactorsMiddle AgedProgestinsAntineoplastic Agents, HormonalPregnancy

Author keywords

endometrial carcinomaendometrial intraepithelial neoplasiafertility‐sparing treatmentslong‐term follow‐upprogestin

Substances

ProgestinsAntineoplastic Agents, Hormonal

Authors and institutions

  • Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei, Taiwan.
  • Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Department of Obstetrics and Gynecology, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu City, Taiwan.

ORCID profiles: Ya-Ting Hsu, Heng-Cheng Hsu, Chi-Hau Chen

Funding

  • National Taiwan University Hospital

Cite

APA

Hsu, Y. T., Hsu, H. C., Lee, C. Y., Hung, W. T., & Chen, C. H. (2025). Long‐term outcomes of fertility‐sparing treatment in endometrial carcinoma and endometrial intraepithelial neoplasia: Recurrence risk factors over a 9‐year follow‐up. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.70028

Vancouver

Hsu YT, Hsu HC, Lee CY, Hung WT, Chen CH. Long‐term outcomes of fertility‐sparing treatment in endometrial carcinoma and endometrial intraepithelial neoplasia: Recurrence risk factors over a 9‐year follow‐up. Acta Obstetricia et Gynecologica Scandinavica. 2025. doi:10.1111/aogs.70028

BibTeX
@article{Hsu2025,
  author = {Hsu, Ya-Ting and Hsu, Heng-Cheng and Lee, Chia-Yi and Hung, Wan-Ting and Chen, Chi-Hau},
  title = {Long‐term outcomes of fertility‐sparing treatment in endometrial carcinoma and endometrial intraepithelial neoplasia: Recurrence risk factors over a 9‐year follow‐up},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2025},
  doi = {10.1111/aogs.70028}
}
Start for free →